Pluristem Therapeutics (PSTI) – Litigation
-
Pluristem Therapeutics (PSTI) Announces European Patent Covering PLX-R18 in Chemotherapy, ARS, Genetic Disorders and Autoimmune Diseases
-
Pluristem Therapeutics (PSTI) Awarded Two New Patents in Hong Kong for Critical Limb Ischemia and Muscle Regeneration
-
-
-
-
-
-
Back to PSTI Stock Lookup